Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Molecules (Basel, Switzerland)|March 15, 2018
Recent Advances in Zirconium-89 Chelator DevelopmentNikunj B Bhatt, Darpan N Pandya, Thaddeus J Wadas
EJNMMI Radiopharmacy and Chemistry|June 21, 2025
Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progressAbdelrahman Homedan, Darpan N Pandya, Nicholas J Schnicker, et al.
Chemical Communications (Cambridge, England)|January 6, 2015
Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89Darpan N Pandya, Sylvie Pailloux, David Tatum, et al.
AJR. American Journal of Roentgenology|July 24, 2014
Molecular targeted α-particle therapy for oncologic applicationsThaddeus J Wadas, Darpan N Pandya, Kiran Kumar Solingapuram Sai, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Cryo-electron microscopy reveals a single domain antibody with a unique binding epitope on fibroblast activation protein alphaZhen Xu, Akesh Sinha, Darpan N Pandya, et al.
Plos One|June 3, 2017
Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89Nikunj B Bhatt, Darpan N Pandya, Jide Xu, et al.
Molecules (Basel, Switzerland)|February 13, 2026
Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate CancerAkesh Sinha, Darpan N Pandya, Prabhakar Eeka, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
A pipeline for facile cloning of antibody Fv domains and their expression, purification, and characterization as recombinant His-tagged IgGsAkesh Sinha, Jinha M Park, Naveed Gulzar, et al.
Pageof 4